Longboard Pharmaceuticals is being acquired by Lundbeck for $60 per share, valuing the deal at $2.6 billion. Read more on ...

At the request of CIRO, Bright Minds Biosciences Inc. (CSE: DRUG) (NASDAQ: DRUG) ("Bright Minds" or the "Company") wishes to confirm that the Company's management is unaware of any material changes in ...

The serotonergic agent fenfluramine was removed from the market in 1997 after being linked to valvular heart disease. Phenylpropanolamine, a sympathomimetic compound subsequently associated with ...

Pharmacogenomics. 2012;13(2):223-231.

while minimizing the side effects, thereby creating superior drugs to first- generation compounds, such as fenfluramine, psilocybin, LSD, and ibogaine.